Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias
脑小血管疾病负担以及血管性认知障碍和阿尔茨海默病及其相关痴呆的种族差异
基本信息
- 批准号:10214110
- 负责人:
- 金额:$ 150.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmericanAmericasAnatomyAncillary StudyBlood VesselsBrainCerebral small vessel diseaseConsensusDeltastabDementiaDevelopmentDistrict of ColumbiaEpidemiologyEvaluationEventGeneticGenetic RiskGenotypeGeographic stateGeographyGoalsGrowthHigh PrevalenceHispanicsHomeHospitalsHypertensionImageImpaired cognitionIncidenceIndividualInternationalLesionMRI ScansMagnetic Resonance ImagingMeasuresMediator of activation proteinMethodologyMinority GroupsNot Hispanic or LatinoOlder PopulationParticipantPatternPhenotypePopulationPopulation HeterogeneityPrevalencePrevention strategyProspective cohort studyRecoveryReportingResearchResourcesRetrievalRiskRisk FactorsRoleSeveritiesStrokeStroke BeltTREM2 geneTelephoneTestingTimeTransient Ischemic AttackVariantVascular Cognitive ImpairmentVascular DementiaWhite Matter HyperintensityWomanadjudicationanalysis pipelineapolipoprotein E-4baseblack menblack womenblack/white disparitybrain volumeburden of illnesscarrier statuscerebral microbleedscognitive reservecognitive testingcohortdementia riskdesigndetectordisorder riskexperiencegenetic risk factorgeographic differencegray matterhigh risk populationmenneuroimagingparent grantpost strokeracial differenceracial disparityrisk variantsocioeconomicsstroke incidencestroke riskstudy populationtreatment strategyvascular cognitive impairment and dementiavascular risk factor
项目摘要
PROJECT ABSTRACT
With an increasing proportion of the population at older ages (i.e., the `graying of America'), there is a growing
prevalence of Alzheimer's Disease and Related Dementias (ADRDs). The increase in proportion of older
Americans is happening at a faster rate among minority populations compared with non-Hispanic Whites
(NHWs), for instance, the number of “oldest” Americans is expected to grow by 81% among non-Hispanic Whites
compared to 131% growth among Non-Hispanic Blacks (NHBs) and 328% among Hispanics, by the year 2030.
Paralleling this increased racial disparity in the proportion of oldest Americans, is also a racial disparity in the
incidence and prevalence of ADRDs. For instance, there is significantly higher prevalence of all dementias
among NHBs compared to NHWs, with NHB men and women having a 2 – 2.5 times the prevalence among
NHW men or women. Among NHB men, the prevalence of Alzheimer's dementia (AD) is 2.5 times that among
NHW men. When only vascular cognitive impairment and dementia (VCID) is examined, NHBs were more than
twice as likely to develop VCID even after adjusting for differences in cumulative incidence of stroke, stroke
severity and known vascular and dementia risk factors. Suggesting the need to identify other factors that could
be contributing to the observed racial or black-white disparity. Our overall goals are to (1) determine whether
there is a black-white disparity in the prevalence of magnetic resonance imaging (MRI) defined markers of CSVD
among participants in the REGARDS cohort with confirmed stroke/TIA and (2) identify the contributions of CSVD
and ADRD genetic and vascular risk factors to the black-white disparity in VCIDs) and ADRDs. We hypothesize
that among REGARDS participants who had a stroke or TIA, the black-white disparity in the prevalence and
trajectory of VCI and ADRDs is partly due to black-white disparity in the prevalence and burden of CSVD, which
could be related to differences in the distribution of vascular and ADRD genetic risk factors. CSVDs are MRI
detected brain lesions whose components are cerebral microbleeds (CMBs), white matter hyperintensity (WMH)
lesions, lacunes and enlarged perivascular spaces (ePVS) and are associated with vascular risk factors as well
as incidence and prevalence of cognitive impairment and dementia. Our hypothesis will be tested based on the
following aims: (1) Determine the prevalence, pattern and racial/geographic difference in CSVD and variation in
brain volumetric parameters. (2) Examine the association between vascular and genetic (APOE ε4, ABCA7 and
TREM2) risk factors, and prevalence or disparity in CSVD and brain volumes. (3) Determine the association
between CSVD, brain volumetric measures and incidence, prevalence and trajectory as well as any observed
black-white disparity in risk of cognitive impairment and dementia. Completing the above aims will enable us to
identify a high-risk population for more targeted VCID prevention or treatment strategies to potentially reduce
black-white disparity in VCID. Additionally, the MRI scans retrieved, and the phenotype derived will be a useful
resource for further research in REGARDS.
项目摘要
随着年龄较大的人口比例越来越多(即“美国的灰色”),越来越多
阿尔茨海默氏病和相关痴呆症(ADRDS)的患病率。年龄较大的比例增加
与非西班牙裔白人相比,美国人的发生率更快
(NHWS),例如,非西班牙裔白人的“最古老”美国人的数量预计将增长81%
到2030年,非西班牙裔黑人(NHB)的增长率为131%,西班牙裔人的增长率为328%。
在最古老的美国人比例中,这种增加的种族差异并行,也是种族差异
ADRD的发病率和患病率。例如,所有痴呆症的患病率显着较高
与NHW相比,NHB中的NHB男性和女性的患病率是2 - 2.5倍
NHW男女。在NHB男性中,阿尔茨海默氏症的痴呆症患病率(AD)是
NHW男子。当仅检查血管认知障碍和痴呆(VCID)时,NHB就超过
即使调整了中风累积事件的差异后,发展VCID的可能性是两倍
严重性和已知的血管和痴呆症风险因素。建议需要确定其他可能的因素
有助于观察到的种族或黑白差异。我们的总体目标是(1)确定是否
磁共振成像(MRI)定义的CSVD标记物的患病率存在黑白差异
在与确认的中风/TIA的参与者中,(2)确定CSVD的贡献
VCID和ADRD的黑白差异的ADRD遗传和血管危险因素。我们假设
在遇到中风或TIA的参与者中,患病率的黑白差异
VCI和ADRD的轨迹部分是由于CSVD的患病率和伯恩的黑白差异
可能与血管和ADRD遗传危险因素的分布差异有关。 CSVD是MRI
检测到的脑病变,其成分是脑微孔(CMB),白质超强度(WMH)
病变,lacusnes和血管周间空间(EPV)也与血管危险因素有关
作为认知障碍和痴呆症的事件和患病率。我们的假设将根据
以下目的:(1)确定CSVD的患病率,模式和种族/地理差异和变化
脑容量参数。 (2)检查血管与遗传之间的关联(ApoEε4,ABCA7和
TREM2)危险因素,CSVD和大脑体积的患病率或差异。 (3)确定关联
在CSVD,脑容量测量和入射,患病率和轨迹之间以及任何观察到的
认知障碍和痴呆症风险的黑白差异。完成上述目标将使我们能够
确定一个高风险人群,以实现更有针对性的VCID预防或治疗策略,以减少
VCID中的黑白差异。此外,还检索了MRI扫描,并且得出的表型将是有用的
用于进一步研究的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hyacinth Idu Hyacinth其他文献
The Role of P-Selectin in Microvascular Hemodynamics and Cerebral Brain Volumes in Aging Sickle Cell Mice
- DOI:
10.1182/blood-2023-189295 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Jahnavi Gollamudi;Rowan Goldin;Paul Territo;Hyacinth Idu Hyacinth - 通讯作者:
Hyacinth Idu Hyacinth
Hyacinth Idu Hyacinth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hyacinth Idu Hyacinth', 18)}}的其他基金
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer’s disease and its related dementias
脑小血管疾病负担以及血管性认知障碍和阿尔茨海默病及其相关痴呆的种族差异
- 批准号:
10634706 - 财政年份:2021
- 资助金额:
$ 150.51万 - 项目类别:
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
米诺环素作为镰状细胞病神经炎症和认知缺陷的潜在疗法
- 批准号:
10403833 - 财政年份:2020
- 资助金额:
$ 150.51万 - 项目类别:
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
米诺环素作为镰状细胞病神经炎症和认知缺陷的潜在疗法
- 批准号:
10530629 - 财政年份:2020
- 资助金额:
$ 150.51万 - 项目类别:
Sickle cell disease and the functional circuit of adult-born neurons in the dentate gyrus
镰状细胞病和齿状回中成年神经元的功能回路
- 批准号:
10693540 - 财政年份:2020
- 资助金额:
$ 150.51万 - 项目类别:
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease
米诺环素作为镰状细胞病神经炎症和认知缺陷的潜在疗法
- 批准号:
10319001 - 财政年份:2020
- 资助金额:
$ 150.51万 - 项目类别:
Mechanism of cerebral vaculopathy and stroke in sickle cell disease
镰状细胞病脑血管病和卒中的机制
- 批准号:
10394156 - 财政年份:2017
- 资助金额:
$ 150.51万 - 项目类别:
Mechanism of cerebral vaculopathy and stroke in sickle cell disease
镰状细胞病脑血管病和卒中的机制
- 批准号:
9367468 - 财政年份:2017
- 资助金额:
$ 150.51万 - 项目类别:
Mechanism of cerebral vaculopathy and stroke in sickle cell disease
镰状细胞病脑血管病和卒中的机制
- 批准号:
10385286 - 财政年份:2017
- 资助金额:
$ 150.51万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Neural crest-derived pelvic ganglia and the effects of developmental deficits on lower urinary tract innervation
神经嵴衍生的盆腔神经节和发育缺陷对下尿路神经支配的影响
- 批准号:
10719065 - 财政年份:2023
- 资助金额:
$ 150.51万 - 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
- 批准号:
10717111 - 财政年份:2023
- 资助金额:
$ 150.51万 - 项目类别:
Generation of a new Cre-deleter mouse line to study spermiogenesis
生成新的 Cre-deleter 小鼠品系以研究精子发生
- 批准号:
10668012 - 财政年份:2023
- 资助金额:
$ 150.51万 - 项目类别:
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 150.51万 - 项目类别: